Literature DB >> 3178175

Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia.

S J Kish1, M el-Awar, L Schut, L Leach, M Oscar-Berman, M Freedman.   

Abstract

A cerebral cortical cholinergic reduction in dominantly inherited olivopontocerebellar atrophy (OPCA) was recently described. Although the magnitude of the cholinergic reduction was similar to that observed in Alzheimer's disease (AD), none of the OPCA patients was reported to have been demented. We now describe a comprehensive neuropsychological assessment of 11 patients from one of the OPCA pedigrees which we examined biochemically. Detailed neuropsychological testing disclosed previously unrecognized deficits in verbal and nonverbal intelligence, memory, and frontal system function which were positively correlated with the severity of cerebellar ataxia. However, our OPCA patients appeared to be at most only mildly disabled by their cognitive impairment and scored within or close to the normal range on a simple mental status screening examination. This, as well as an absence of any aphasia, apraxia, or agnosia, contrasts with the profile and severity observed in advanced AD dementia, characterized by a similar cortical cholinergic deficit. This finding also suggests that cholinergic reduction may explain only part of the pathophysiology underlying the dementia of AD.

Entities:  

Mesh:

Year:  1988        PMID: 3178175     DOI: 10.1002/ana.410240205

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

2.  Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy.

Authors:  G Finali; M Piccirilli; C Oliani; G L Piccinin
Journal:  Ital J Neurol Sci       Date:  1992-03

Review 3.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.

Authors:  Melissa Asher; Juao-Guilherme Rosa; Orion Rainwater; Lisa Duvick; Michael Bennyworth; Ruo-Yah Lai; Sheng-Han Kuo; Marija Cvetanovic
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

Review 5.  Amnestic disorders. Pathophysiology and patterns of memory dysfunction.

Authors:  K R Erickson
Journal:  West J Med       Date:  1990-02

Review 6.  Mind the gaps: What we don't know about cognitive impairment in essential tremor.

Authors:  Elan D Louis; Jillian L Joyce; Stephanie Cosentino
Journal:  Parkinsonism Relat Disord       Date:  2019-03-01       Impact factor: 4.891

7.  Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy.

Authors:  S J Kish; Y Robitaille; M el-Awar; L Schut; L DiStefano; M J Ball; M F Mazurek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

Review 8.  Cholinergic modulation of the cortical neuronal network.

Authors:  E Lucas-Meunier; P Fossier; G Baux; M Amar
Journal:  Pflugers Arch       Date:  2003-03-05       Impact factor: 3.657

Review 9.  The effects of cerebellar damage on maze learning in animals.

Authors:  R Lalonde; C Strazielle
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

10.  The cognitive side of essential tremor: what are the therapeutic implications?

Authors:  Sarah C Janicki; Stephanie Cosentino; Elan D Louis
Journal:  Ther Adv Neurol Disord       Date:  2013-11       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.